| 1 |
吴长东，侯 铭，杨 嵘，等. 联合检测二维超声心动图，BNP，6MWT，MMRC对慢性阻塞性肺疾病急性加重期患者右心功能不全的诊断意义[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(4): 441-444.
|
| 2 |
Halpin DMG, Criner GJ, Papi A, et al. The 2020 GOLD Science Committee Report on COVID-19 and chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2021, 203(1): 24-36.
|
| 3 |
李建华，陶绍辉，何雨峰，等. 白细胞介素-6，降钙素原和D-二聚体联合检测在慢性阻塞性肺疾病急性加重期细菌感染患者中的表达及与预后的相关性研究[J]. 贵州医药，2019, 43(10): 3.
|
| 4 |
徐国建，徐淑慧，李春雅，等. 慢性阻塞性肺疾病急性加重伴慢性呼吸衰竭凝血纤溶与炎症因子及肺功能的相关性分析[J]. 中国卫生检验杂志，2019, 29(3): 78-80, 83.
|
| 5 |
谢国钢，田 雪，丁凤鸣，等. 血浆D-二聚体水平与慢性阻塞性肺疾病患者急性加重再住院的关系研究[J]. 中国医师进修杂志，2019, 42(11): 5-12.
|
| 6 |
慢性阻塞性肺疾病急性加重(AECOPD)诊治专家组．慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(2017年更新版)[J]. 国际呼吸杂志，2017, 37(14): 1041-1057.
|
| 7 |
Lamba TS, Sharara RS, Singh AC, et al. Pathophysiology and classification of Respiratory Failure[J]. Crit Care Nurs Q, 2016, 39(2): 85-93.
|
| 8 |
Su Y, Wang M, Liu Y, et al. Module modified acute physiology and chronic health evaluation Ⅱ：predicting the mortality of neuro-critical disease[J]. Neurol Res, 2014, 36(12): 1099-1105.
|
| 9 |
高美丽，赛亚飞，金发光，等. 慢性阻塞性肺疾病急性加重期患者病原菌分布特点[J/CD]. 中华肺部疾病杂志(电子版), 2019, 28(4): 26-31.
|
| 10 |
Yang IA, Jenkins CR, Salvi SS. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment[J]. Lancet Respir Med, 2022, 10(5): 497-511.
|
| 11 |
Ni H, Aye SZ, Naing C. Magnesium sulfate for acute exacerbations of chronic obstructive pulmonary disease[J]. Cochrane Database Syst Rev, 2022, 5(5): 506-512.
|
| 12 |
Martinez FJ, Agusti A, Celli BR, et al. Treatment trials in young patients with chronic obstructive pulmonary disease and pre-chronic obstructive pulmonary disease patients: time to move forward[J]. Am J Respir Crit Care Med, 2022, 205(3): 275-287.
|
| 13 |
任成山，王关嵩，钱桂生. 慢性阻塞性肺疾病的成因及其治疗的困惑与希望[J/CD]. 中华肺部疾病杂志(电子版), 2019, 12(2): 127-141.
|
| 14 |
朱聪聪，毛科稀，叶旭军. 慢性阻塞性肺疾病急性加重期患者治疗前后C-反应蛋白水平和凝血-纤溶功能变化[J]. 微循环学杂志，2019, 29(4): 3-8.
|
| 15 |
Di J, Li X, Xie Y, et al. Procalcitonin-guided antibiotic therapy in AECOPD patients: Overview of systematic reviews[J]. Clin Respir J, 2021, 15(6): 579-594.
|
| 16 |
Ritchie AI, Wedzicha JA. Definition, causes, pathogenesis, and consequences of chronic obstructive pulmonary disease exacerbations[J]. Clin Chest Med, 2020, 41(3): 421-438.
|
| 17 |
莫如敦，石 慧，韦 玲，等. 血清TREM-1、SAA检测在AECOPD并发呼吸衰竭诊断及预后评估中的价值[J]. 中国实验诊断学，2019, 23(3): 8-12.
|
| 18 |
曹秀丽，李有香. 血浆D-二聚体水平与慢性阻塞性肺疾病伴低危肺栓塞患者预后的相关性[J]. 中国临床研究，2020, 33(7): 5-10.
|
| 19 |
陈 庆，吴 亚，蒋才玉，等. APACHE-Ⅱ、PCT、ALB及CRP对慢性阻塞性肺疾病机械通气患者预后影响的临床研究[J]. 四川医学，2020, 41(1): 29-32.
|
| 20 |
Yang R, Liu G, Deng C. Pulmonary embolism with chronic obstructive pulmonary disease[J]. Chronic Dis Transl Med, 2021, 7(3): 149-156.
|
| 21 |
Liu M, Hu R, Jiang X, et al. Coagulation dysfunction in patients with AECOPD and its relation to infection and hypercapnia[J]. J Clin Lab Anal, 2021, 35(4): 33-36.
|
| 22 |
Gosker HR, Langen RC, Simons SO. Role of acute exacerbations in skeletal muscle impairment in COPD[J]. Expert Rev Respir Med, 2021, 15(1): 103-115.
|
| 23 |
Meeraus WH, DeBarmore BM, Mullerova H, et al. Terms and definitions used to describe recurrence, treatment failure and recovery of acute exacerbations of COPD: a systematic review of observational studies[J]. Int J Chron Obstruct Pulmon Dis, 2021, 16(35): 3487-3502.
|
| 24 |
van der Vorm LN, Li L, Huskens D, et al. Acute exacerbations of COPD are associated with a prothrombotic state through platelet-monocyte complexes, endothelial activation and increased thrombin generation[J]. Respir Med, 2020, 171(28): 94-98.
|
| 25 |
罗玉爱，王 捷，李贤英. 急性生理学与慢性健康状况评分Ⅱ联合血清D-二聚体，肌钙蛋白Ⅰ及脑钠肽水平测定对慢性阻塞性肺疾病患者预后评估价值[J]. 临床军医杂志，2021, 49(7): 12-16.
|
| 26 |
安铁峰，谢苗荣，王文科，等. 血清肾上腺髓质素原，降钙素原，D-二聚体水平对急诊慢性阻塞性肺疾病急性加重并Ⅱ型呼吸衰竭患者预后的预测价值[J]. 实用心脑肺血管病杂志，2019, 27(6): 6-10.
|